Federal Register of Legislation - Australian Government

Primary content

Notices & Notifications as made
This notice has the effect of requiring that therapeutic goods that contain 'glutathione' as a therapeutically active ingredient, subject to certain conditions, be included in the part of the Australian Register of Therapeutic Goods (the Register) for listed goods.
Administered by: Health
Made 03 Sep 2014
Registered 25 Sep 2014
Tabled HR 30 Sep 2014
Tabled Senate 30 Sep 2014
Date of repeal 21 Oct 2016
Repealed by Therapeutic Goods (Repeal of Listing Notices) Notice 2016

 

 

Therapeutic Goods Act 1989

 

 

I, JOHN SKERRITT, National Manager of the Therapeutic Goods Administration, delegate of the Minister for Health for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the Register) for listed goods:

 

·         preparations, for the purpose of Item 3 of Part 1 of Schedule 4 to the Therapeutic Goods Regulations 1990 (the Regulations), that contain ‘glutathione’ as a therapeutically active ingredient, subject to the following conditions:

o   the preparations are for oral use only; and

 

o   the preparations are for use in adults only; and

 

o   the preparations are not indicated for use in pregnant or lactating women.

                                                                                                                

This Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.

 

Pursuant to subsection 9A(6) of the Act, this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the Register for listed goods.

 

 

 

Dated this 3rd day of September 2014

 

 

(Signed by)

 

 

John Skerritt

Delegate of the Minister for Health